Kiromic BioPharma (KRBP) News Today $2.03 0.00 (0.00%) (As of 09/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period August 14, 2024 | stockhouse.comKiromic BioPharma's Deltacel Receives FDA Fast Track DesignationAugust 13, 2024 | finance.yahoo.comKiromic reports update from Phase I NSCLC treatment trialAugust 9, 2024 | finance.yahoo.comKiromic BioPharma Provides Update on Part 1 of the Deltacel-01 TrialAugust 1, 2024 | finance.yahoo.comKiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01July 20, 2024 | finance.yahoo.comKiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion PhaseJune 20, 2024 | businesswire.comKiromic BioPharma Provides Updates on its Deltacel-01 Clinical TrialJune 6, 2024 | businesswire.comKiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical TrialMay 29, 2024 | markets.businessinsider.comKiromic BioPharma's Deltacel-01 Phase 1 Trial Shows Early Efficacy At Sixth WeekMay 29, 2024 | businesswire.comKiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical TrialMay 20, 2024 | businesswire.comKiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial SiteMay 13, 2024 | investorplace.comKRBP Stock Earnings: Kiromic BioPharma Reported Results for Q1 2024April 26, 2024 | uk.investing.comDeltacel shows promise in Kiromic BioPharma lung cancer trial, Kiromic seeks FDA fast trackApril 24, 2024 | finance.yahoo.comKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsApril 10, 2024 | msn.comKiromic BioPharma files to withdraw registration statementApril 2, 2024 | businesswire.comKiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical TrialMarch 19, 2024 | finance.yahoo.comEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialMarch 19, 2024 | businesswire.comEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical TrialMarch 1, 2024 | businesswire.comKiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialFebruary 28, 2024 | finance.yahoo.comKiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thFebruary 28, 2024 | businesswire.comKiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7thFebruary 14, 2024 | finance.yahoo.comResults from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsFebruary 14, 2024 | businesswire.comResults from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsJanuary 29, 2024 | finance.yahoo.comKiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerJanuary 5, 2024 | finance.yahoo.comKiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical TrialDecember 14, 2023 | finance.yahoo.comKiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung CancerNovember 16, 2023 | finance.yahoo.comKiromic BioPharma Announces Uplisting to OTCQB MarketNovember 9, 2023 | finance.yahoo.comKiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer CenterNovember 1, 2023 | morningstar.comKiromic BioPharma Inc Ordinary SharesOctober 23, 2023 | finance.yahoo.comKiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial AgreementSeptember 15, 2023 | uk.investing.comStaidson Beijing Biopharma (300204)September 13, 2023 | finance.yahoo.comKiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14July 24, 2023 | finance.yahoo.comKiromic BioPharma Welcomes Two New Directors to its BoardJuly 12, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 09:07 AM with a stated reason of "LULD pause."June 30, 2023 | marketwatch.comKiromic Biopharma Shares Down 12% After Stock Offering ProspectusJune 10, 2023 | bizjournals.comFounder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing roundJune 10, 2023 | finance.yahoo.comKRBP - Kiromic BioPharma, Inc.June 8, 2023 | theglobeandmail.comInstrument Name Kiromic Biopharma Inc Instrument Symbol (KRBP-Q)May 22, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 12:05 PM with a stated reason of "LULD pause."May 10, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 01:05 PM with a stated reason of "LULD pause."May 8, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 03:05 PM with a stated reason of "LULD pause."May 8, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 02:05 PM with a stated reason of "LULD pause." Trading set to resume at 02:05 PM. May 4, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | finance.yahoo.comWhat's Going On With Kiromic BioPharma Stock WednesdayMay 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 03:05 PM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 11:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause."May 3, 2023 | marketbeat.comTrading was temporarily halted for "KRBP" at 10:05 AM with a stated reason of "LULD pause." Get Kiromic BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address “A very dark day is coming to America” (Ad)Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed to America's shores – and it scares the hell out of Wall St. legend Louis Navellier. When it makes landfall, its impact will be more violent and more severe than any financial crisis we've ever seen… "No matter how prepared you think you are, you aren't prepared enough," he warns. Click here to see his official warning. KRBP Media Mentions By Week KRBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRBP News Sentiment▼0.000.45▲Average Medical News Sentiment KRBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRBP Articles This Week▼00▲KRBP Articles Average Week Get Kiromic BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TENK News Today FBRX News Today GLYC News Today IMNN News Today PHXM News Today KPRX News Today AGRX News Today KZIA News Today CDT News Today VCNX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRBP) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredKamala’s Promise Will Kill America (Revealed)Kamala’s 3-Word Plan to Destroy America — Are You Prepared? Discover the secret plan that will bankrupt eve...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiromic BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiromic BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRBP Stock Alerts